REVANCE THERAPEUTICS

Revance Therapeutics is a biopharmaceutical company, engages in developing and commercializing products and treatments in dermatology and aesthetic medicines. Its products include RT001, a physician-applied topical botulinum toxin type A (BoNT-A) for cosmetic, hyperhidrosis, and dermatologic indications. The company was formerly known as Essentia Biosystems, Inc. Revance Therapeutics, Inc. was founded in 2002 and is based in Mountain View, California.

REVANCE THERAPEUTICS

Social Links:

Facebook

Twitter

Industry:

Biotechnology Health Care Pharmaceutical Therapeutics

Founded:

2002-01-01

Address:

Newark, California, United States

Country:

United States

Website Url:

http://www.revance.com

Total Employee:

101+

Status:

Active

Contact:

+1 510 742 3400

Email Addresses:

[email protected]

Total Funding:

1.49 B USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins

Similar Organizations

1717-life-science-ventures-logo

1717 Life Science Ventures

1717 Life Science Ventures develops precision radiopharmaceuticals for the diagnosis and treatment of malignant oncological diseases.

aclaris-therapeutics-logo

Aclaris Therapeutics

Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.

akebia-therapeutics-logo

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

lucy-therapeutics-logo

Lucy Therapeutics

Lucy Therapeutics is a biotech company providing effective treatments for neurological diseases start with the mitochondria.

pliant-therapeutics-logo

Pliant Therapeutics

Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.

proventiv-therapeutics-logo

Proventiv Therapeutics

Proventiv Therapeutics develops and commercializes pharmaceutical products to treat and prevent the clinical consequences of diseases.

not_available_image

Secant Therapeutics

Secant Therapeutics develops a percutaneous transcatheter direct plication annuloplasty (DPA) device.

Current Advisors List

mark-foley_image

Mark Foley Board Member @ Revance Therapeutics
Board_member
2017-09-01

phyllis-gardner_image

Phyllis Gardner Director @ Revance Therapeutics
Board_member

bob-byrnes_image

Bob Byrnes Independent Director @ Revance Therapeutics
Board_member

david-l-douglass_image

David L. Douglass Board Observer @ Revance Therapeutics
Board_observer

jim-glasheen_image

Jim Glasheen Board Director @ Revance Therapeutics
Board_member

Current Employees Featured

todd-gross_image

Todd Gross
Todd Gross Vice President, Biostatistics & Data Management @ Revance Therapeutics
Vice President, Biostatistics & Data Management
2018-08-01

abhay-joshi_image

Abhay Joshi
Abhay Joshi COO, President of R&D and Product Operations @ Revance Therapeutics
COO, President of R&D and Product Operations
2015-12-01

ben-de-waal_image

Ben de Waal
Ben de Waal Vice President, Platform Research and Development @ Revance Therapeutics
Vice President, Platform Research and Development
2020-07-01

mark-foley_image

Mark Foley
Mark Foley President & CEO @ Revance Therapeutics
President & CEO
2019-10-01

not_available_image

Sharon Hall
Sharon Hall Vice President, Regulatory Affairs @ Revance Therapeutics
Vice President, Regulatory Affairs

tobin-schilke_image